18º Congresso Brasileiro de Neurologia Infantil

Dados do Trabalho



Apresentação do caso

A female patient, 4 months old, diagnosed with Spinal Muscular Atrophy Type I by genetic test using the Multiplex Ligation-dependent Probe Amplification (MLPA) technique and with respiratory failure manifestations in the first weeks of life. Due to this acute condition, in the emergency service, the patient was admitted to the hospital, initially using Continuous Positive Airway Pressure (CPAP) and later requiring orotracheal intubation due to worsening of the respiratory condition. After Nusinersena (4 doses) was administered, extubation measures were taken.
Even with clinical complications, such as pneumothorax and episodes of bradycardia, the patient was kept on non-invasive ventilation, and ventilatory support measures were used, such as Cough Assist and physiotherapy maneuvers, and she was discharged after 115 days of hospitalization, without tracheostomy.


Spinal Muscular Atrophy is a genetic disease involving cell death of motor neurons located in the anterior horn of the spinal cord and brainstem motor nuclei, caused by SMN1 gene mutations. Type 1 is the most severe form, presenting with areflexia, inability to sit without support, severe hypotonia, and diffuse muscle weakness. Respiratory failure is usually the cause of death in these patients between 12 and 36 months of age, caused by profound neurogenic muscle atrophy leading to inability to cough, weakness and fatigue of the respiratory muscles. It can develop from progressive ventilatory decompensation or from an acute process such as pneumonia.
Among the types of respiratory management, tracheostomy can be performed when patients are unable to wean themselves off ventilatory support. However, it makes speech development difficult or impossible, leads to dependence due to loss of respiratory autonomy, and brings complications such as repeated infections.
In contrast, non-invasive ventilation associated with adequate physiotherapy assistance offers good results, with fewer hospitalizations allowing home admission, speech capacity and increased life expectancy.
In this report, it was observed that the choice not to perform a tracheostomy was beneficial, enabling the indication of Zolgensma according to criteria for supply via the Unified Health System.

Comentários finais

It is necessary to promote a better quality of ventilation and suction of patients with SMA type 1, seeking to increase the patient's quality of life, against tracheostomy as the best treatment option.

Referências (se houver)

Palavras Chave

Tracheostomy; SMA type 1; Noninvasive ventilation

Fonte de Fomento (se houver)

Declaração de conflito de interesses de TODOS os autores

All the authors of this work entitled "RESPIRATORY MANAGEMENT WITH NON INVASIVE VENTILATION OF A CHILD WITH SPINAL MUSCULAR ATROPHY TYPE I: CASE REPORT", declare that they have no personal, commercial, political or financial conflict of interest for the development of this work.


Doenças neuromusculares


Centro Universitário Barão de Mauá - São Paulo - Brasil, Hospital Materno Infantil Sinhá Junqueira - São Paulo - Brasil


Isabela Grozza Cestari, Júlia de Lima Alves, Carolina Guimarães Moura, Júlia Mazaroski, Caroline Maria de Lima Verza, Isabella Cristina Mendes de Sá e Silva, Jessica Rios Braga Vilela Silva